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Although there is considerable controversy about the proper management of the solitary
nodule, certain information may be useful in reaching this decision. Age, sex, and a previous
history of external irradiation to the head and neck are helpful as are the clinical characteristics
of the thyroid gland. Whether the nodule is functioning or "cold" on thyroid scan, and cystic or
solid on thyroid ultrasound is also helpful. Based on these findings, the physician must decide
whether to recommend surgery or thyroid hormone suppressive therapy.
SOLITARY THYROID NODULES
Proper management of the solitary thyroid nodule is perhaps the area of greatest
controversy among thyroidologists. This controversy continues because it is possible
to obtain statistics to support any stand one wishes to take.
One of the major problems in estimating the risk of malignancies in thyroid
nodules is to eliminate bias in case selection. We attempted to do this by studying
patients with thyroid nodules who were referred for radioisotopic scan ofthe thyroid
gland [1]. Presumably, most physicians would obtain a radioisotopic scan before
making anytherapeutic decision. There were l030 patients with solitary "cold"thyroid
nodules and 68 of these patients came to thyroid surgery. Thyroid carcinoma was
found in 18 percent of patients at surgery. Whether case selection occurred to any
significant extent in the patients referred to surgery is not clear. However, even if no
further malignancies were found, the incidence of thyroid carcinoma in these
presumably unselected patients with solitary cold thyroid nodules would be about 9
percent.
Factors Predisposing to Thyroid Cancer
The possibility of malignancy is clearly increased in solitary "cold" thyroid nodules
and it is important to obtain further criteria to select those patients most at risk.
Sex
All forms ofthyroid disease are more common in females and this is true ofthyroid
malignancy as well. However, non-toxic nodular goiter is even more common than
malignancy in females than in males. As a consequence, a solitary thyroid nodule
occurring in a male is more likely to be malignant than a solitary nodule occurring in
a female.
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Age
Estimates have indicated than one-half the thyroid nodules appearing in children
may be malignant. The implication is not that thyroid cancer is more common in
childhood but, rather, that thyroid nodules in general are uncommon in this age
group. Eighty percent of the children with carcinoma of the thyroid who formed the
basis of this estimate had a past history of radiation [2,3]. The chance ofmalignancy
in the thyroid nodule of children needs to be reappraised now that this type of
irradiation has been practically discontinued.
In one study of 30 children with solitary thyroid nodules, only four children had a
previous history of neck irradiation [4]. Nevertheless, there was still a 40 percent
incidence of carcinoma in the series includingthefour irradiated children. Thesedata
would suggest that thyroid carcinoma continues to be a significant risk in children
with solitary thyroid nodules. However, in a study of5,179 school children in Grades
6 through 12, nodularity of the thyroid was found in 93, 1.8 percent [5]. The
nodularity represented adolescent goiter in 34 children and thyroiditis in 31. Benign
adenomas were found in 20 and only two thyroid cancers were found. The 28 thyroid
nodules that proved to be neoplasms were discrete, solitary, offirm consistency, and
without changes in the rest of the thyroid.
Previous Irradiation ofthe Head and Neck
Previous irradiation of the head and neck markedly increases the chances of
malignancy in a thyroid nodule. The observation in 1950 that nine of twenty-eight
children with carcinoma of thyroid had been given radiotherapy to the thymus in
infancy first highlighted this association, which was later confirmed in prospective
studies [6,7]. Most instances of thyroid malignancy following neck radiation had
been reported within 10 years after radiation therapy. Since this type of radiation
therapy to the neck had been virtually discontinued, a degree of complacency
developed among many physicians. However, recent reports indicating an increased
incidence ofthyroid carcinoma, an average of25 years after radiation exposure to the
head and neck, have dispelled this illusion [8]. Despite direct questioning, few
patients with a thyroid nodule were able to give a history ofradiation during infancy.
Public awareness increased dramatically after the relationship was featured in a
television drama.
The exact magnitude of the increase in thyroid carcinoma after irradiation to the
neck is unknown because appropriate age-matched control data are sparse. How-
ever, the increase in thyroid carcinoma is significant, and estimates have ranged from
a twofold to a one hundredfold increase in the frequency of thyroid cancer.
PHYSICAL CHARACTERISTICS
Careful examination of the thyroid can be extremely helpful in determining the
proper degree of suspicion of underlying malignancy. A history of recent thyroid
growth, dysphagia, or dyspnea should make the examiner suspicious of malignancy.
Palpation of the thyroid should be done carefully with particular attention to the
regularity and hardness of the nodule, whether the gland is fixed to surrounding
structures and whether there are palpable regional lymph nodes. On the other hand,
the presence of a multinodular goiter would decrease the suspicion of malignancy.
A group of patients with thyroid nodules were first classified clinically and these
results were compared to the findings at surgery [9]. Thyroid cancer was found in 76
percent of cases thought to be malignant clinically, 12 percent of cases thought to be
benign clinically but symptomatic as indicated by pain, recent change in goiter size,
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or dysphagia and 3 percent of patients thought to be benign and asymptomatic. In
this particular study of 53 patients, there were only two patients with thyroid
carcinoma who were free of symptoms.
The most important physical sign is the presence of a hard, irregular thyroid
nodule. Extreme hardness may be due to hemorrhage into a cyst with subsequent
calcification. If the thyroid cancer has spread beyond the capsule and invaded
surrounding structures, the clinical diagnosis becomes comparatively simple al-
though Riedel's struma can also extend beyond the gland. Fixation to the strap
muscles, trachea, or larynx is easily detected on physical examination. Recurrent
laryngeal nerve paralysis is not a common presenting symptom in thyroid carcinoma
but does occur.
LABORATORY DIAGNOSIS
The presence of a solitary thyroid nodule raises the question ofthyroid malignancy
and the above predisposing factors may strengthen or allay suspicions in the
individual patient. The next step in the evaluation is to use the laboratory to
discriminate which nodules may be malignant and which may be benign.
Radioactive Scan ofthe Thyroid
Scanning of the thyroid after the administration of a tracer dose of radioactive
iodine or Technetium-99m permits the delineation of functioning and- non-
functioning areas of the thyroid. Since even well-differentiated thyroid carcinomas
do not concentrate iodine as efficiently as normal thyroid, hypofunctioning or "cold"
thyroid nodules have been considered to harbor a greater risk of malignancy. This
classification is established by assessing the amount of radioactivity within the nod-
ule. The "cold" nodule must be approximately one centimeter in diameter. Large
nodules may produce a well-defined focal defect, marginal indentation, or locally
reduced parenchymal activity. Demonstration of a "cold" thyroid nodule is signifi-
cant but unfortunately non-specific. The majority of clinically detectable thyroid
nodules are less functional than the extra-nodular thyroid tissue [10].
Iodine',3' has been the radionuclide most widely used for imaging the thyroid.
Although the high absorbed radiation doses were recognized with concern, this
concern has heightened with the recurrence of interest in the delayed effects of neck
irradiation [I1]. The administration of 100ilc of 1131 for athyroid scan can result in a
dose of 80 rads to the thyroid [12]. Since several scans would deliver a dose of
radiation to the thyroid which has been associated with subsequent thyroid cancer
with external radiation, alternative methods ofthyroid imaging are highly desirable.
Iodine'23 is perhaps the ideal isotope for in vivo diagnostic studies of thyroid
function and structure. The short half life of 13.3 hours is suitable for routine
uptakes. Scans superior in resolution than those afforded by ggm Tc or 1311 can be
obtained with a radiation dose 1/85 that for a comparable1131 scan. However, high
purity 1123 is not generally available, and technetium is probably the most readily
available isotope of choice for thyroid scanning at thepresent time. Technetium-99m
would deliver about 0.6 rads to the thyroid during a scanningperiod. The pertechne-
tate ion (9Im TcO4) is rapidlytrapped bythethyroid but is not organically bound and
does not remain in the gland. The difference between the two radioisotopes has
clinical significance because some thyroid malignancies have trapped pertechnetate
but not 1'1' because of a defect in organification.
The findings in most studies have been consistentwith the physiological considera-
tions discussed above. Most of the thyroid cancers were "cold" but benign thyroid
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nodules were also predominantly "cold." This lack of discrimination makes it diffi-
cult to use the thyroid scan to differentiate between benign and malignant thyroid
nodules. Certainly, no patient with a solitary thyroid nodule should be either selected
for surgery or screened from surgical consideration by a thyroid scan although the
scan would be helpful in eliminating the minority of solitary nodules with increased
uptake from serious consideration of malignancy.
Ultrasound
The presence of a cold nodule on thyroid imaging may indicate either a solid
nodule that does not trap the radionuclide or a cystic area in the gland. Analysis of
the echoes produced by and ultrasonic beam directed into the thyroid nodule may
permit differentiation of the solid nodule from the cystic nodule. Diagnostic
ultrasound employs acoustic properties to distinguish different soft tissues by passing
ultra-high sound frequencies into the nodule and analyzing the reflected echoes. In
solid thyroid nodules, multiple echoes are generated with high sensitivity levels, while
this does not occur in a thyroid cyst.
The thyroid gland is not as acoustically dense as the surrounding tissue. Tracheal
cartilage represents the most dense structure in the area. In addition to distinguishing
between solid and cystic thyroid nodules, enlargement of the thyroid due to tumor
growth can be differentiated from enlargement due to cystic or hemorrhagic
degeneration [13].
Cysts have been reported to occur in 20 percent of solitary thyroid nodules [14].
Although the possibility of malignancy is significant, particularly in a partially cystic
lesion, the incidence is less than in a solid lesion. The use of ultrasound to evaluate
solitary nodules over 4 cm is limited because both solid and cystic lesions of this size
will demonstrate heterogeneous echoes. Small nodules are also difficult, and cystic
lesions less than one centimeter in size may not be identified. Substernal goiters are
difficult to study because the sternum reflects the sound. Despite the useful informa-
tion that can be obtained, ultrasound does not differentiate between a benign and a
malignant thyroid nodule.
Thyroid Biopsy
Although various diagnostic procedures may heighten suspicion that a particular
solitary thyroid nodule is malignant, only a tissue diagnosis will ultimately diagnose
or exclude thyroid cancer. Needle biopsy of the thyroid has been considered as an
alternative to surgery, but fear that cancer might be disseminated along the track
delayed acceptance of this procedure. Although a consideration, possible seeding of
the needle track should not be a major deterrent to needle biopsy ofthe thyroid. The
most difficult thyroid lesions to diagnose are follicular carcinomas, because their
identification often rests on the demonstration ofvascular and capsular invasion. The
small amount of tissue obtained means these areas may be missed. Papillary
carcinoma on the other hand is usually easily identified due to its unique histological
characteristics.
Since the majority of patients who have had a biopsy of the thyroid do not have a
subsequent thyroidectomy, comparison of the biopsy specimen with the entire
thyroid gland is frequently impossible. In a series of 81 cases where 93 percent of
needle biopsy diagnoses were confirmed by thyroid surgery, the errors were due to
lymphoma complicating Hashimoto's disease, undifferentiated carcinoma diagnosed
as non-specific thyroiditis, and follicular carcinoma mistaken for follicular adenoma
328SOLITARY THYROID NODULES
[15]. No serious complications occurred with the needle biopsy procedure and in
none of the primary cancers was there evidence of tumor implantation in the needle
track. However, there was a single example of seeding in a renal cell carcinoma
metastatic to the thyroid. If there is a significant clinical suspicion of thyroid cancer,
a .negative needle biopsy should not deter immediate surgery and is probably not
indicated in such cases.
Thyroid biopsy with a cutting needle has the potential for complications which
have made many physicians cautious about the procedure. Aspiration thyroid biopsy
with a fine needle obviates the risk of serious complications that may occur with
cutting needles like the Vim-Silverman. The amount oftissue obtained is not as great
which may make accurate diagnosis more difficult. However, despite the random
nature of the sampling, the accuracy of the thyroid cytology has been high [16].
Adequate aspirate for cytologic diagnosis can be obtained in 95 percent of cases and
may agree with the histology at surgery in as many as 80 percent of cases.
Nevertheless, the possibility of sampling error is large, and a negative aspiration
biopsy should not influence the therapeutic decision.
MANAGEMENT OF THE SOLITARY THYROID NODULE
A therapeutic decision must be made about the management ofthe solitary thyroid
nodule, and a decision tree for management is outlined in Fig. 1. A solitary thyroid
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nodule occurring in a child or individual with a history of neck irradiation should be
operated upon immediately as should the patient who has a clinically "malignant"
thyroid on physical examination. Before surgery, it is important to be sure that a
solitary nodule does not represent a single thyroid lobe with compensatory hypertro-
phy. In the absence of these immediate indications for surgery, the patient should
have a thyroid scan. If the nodule is functioning, and iffine needle aspiration biopsy
is non-diagnostic, the gland should be suppressed with thyroid hormone for three
months. Disappearance ofthe nodule is an indication for continued thyroid hormone
suppression. An occasional patient may have an autonomous nodule and become
thyrotoxic on thyroid hormone suppression. Therefore, thyroid function tests should
be done several weeks after suppressive therapy has been started. If the response is
incomplete and the patient is a young male, surgery is indicated. Otherwise, thyroid
hormone suppression can be continued for another three-month trial period.
If the solitary thyroid nodule is non-functioning, then ultrasound should be used to
determine whether it is solid or cystic. If it is cystic and aspiration does not reveal
evidence of malignancy, then thyroid hormone suppression can be attempted for
three months. Complete disappearance of the nodule would be an indication for
continued thyroid hormone suppression therapy. A solid non-functioning thyroid
nodule should have a fine needle aspiration biopsy. Ifmalignancy were not found, the
gland would be suppressed with thyroid hormone and managed like the functioning
nodule with treatment depending upon the response.
Thus, although the degree of function in the thyroid nodule is used to separate
patients into two tracks, the tracks are treated in similar manner. The difference
between thyroid hormone suppressive therapy for a diffuse or multinodular goiter
and the solitary nodule is one of degree. The attempt should be made to treat the
solitary nodule with the suppressive dose of thyroid hormone so that the serum TSH
concentration is suppressed as much as possible. Regardless of the dose of thyroid
hormone administered, it is extremely difficult to totally suppress pituitary TSH
secretion. Whether these low circulating levels of TSH actually stimulate the thyroid
is not clear. However, it seems desirable to decrease the circulating concentration of
serum TSH to lowest possible levels.
The question has been raised about the practice of using thyroid hormone
suppression in solitary "cold" nodules with the implication that "cold" means
inactive. Actually, "cold" nodules have been shown to be more active biochemically
than "warm" nodules [17]. They appear to have a defect in iodine trapping but other
parameters such as glucose oxidation and cyclic AMP levels are actually increased.
ln one study, 50 percent of the "cold" nodules did decrease in size with thyroid
hormone therapy [18].
Dose of Thyroid Hormone
The usual suppressive dose of L-thyroxine will range between 200 to 300 ,ug/day.
The amount of thyroxine for suppression ofa solitary thyroid nodule can be adjusted
to a dose just below that giving rise to thyrotoxic symptoms like palpitations, sleep
disturbance, or excessive sweating. However, with elevated thyroid hormone concen-
trations, subclinical hyperthyroidism may result and may be undesirable over the
long term. The TRH test may be helpful in this situation. By adjusting the dose of
thyroxine until the TSH response to TRH is inhibited, hyperthyroidism should be
avoided with effective suppression of TSH. This is probably unnecessary for initial
suppression of the nodule and arbitrary dose of 200 to 250,g/day will suffice.
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Duration ofSuppression
If the patient with a solitary thyroid nodule is to have a trial of thyroid hormone
suppression, it is important to know how long thyroid hormone should be adminis-
tered before deciding that the nodule will not regress with suppression of circulating
TSH. Some patients have not had regression in their goiter until the treatment was
continued for a year or longer. Half the patients receiving thyroid hormone
suppressive therapy for non-toxic goiter had a decrease in the size of their thyroid
nodules after three months. When patients who had not responded were treated for
another four months, one-third of the nodules decreased in size, and it made no
difference whether the dose of thyroid was increased or not. The data suggest a
course oftherapy for at least three months and preferably six months beforedeciding
that the thyroid nodule will not respond to suppression. Re-evaluation at three-
month intervals would allow a management decision based on factors such as sex and
age in addition to response to thyroid hormone.
If the thyroid nodule disappears completely, then thyroid hormone suppression
should be continued indefinitely. Regression of the solitary nodule does not rule out
cancer but does indicate that the nodule is responsive to TSH. Thyroid hormone
should be continued as long as there is no change in the size of the nodule and
immediate surgery advised if the nodule should enlarge while on suppressive therapy.
Ifthe nodule does not regress completely, then the decision whether or not to operate
will depend on the other factors already discussed.
Surgery
If the decision is made to operate, both lobes of the thyroid should be totally
exposed even though the nodule is palpable preoperatively in only one lobe. Multiple
thyroid nodules are discovered at surgery in as many as 60 percent ofcases diagnosed
as a single nodule preoperatively by careful palpation and scan. If multinodular
goiter is discovered at operation, the risk of carcinoma in the thyroid nodule lessens
dramatically but the surgeon should probably go on to remove the lobe thought to
contain the single nodule.
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